Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 2.72 | - | - | - |
Cash Equivalents | 17.00 | 24.82 | 56.94 | 40.36 |
Short Term Investments | 106.15 | 91.33 | 12.86 | 0.00 |
Cashand Short Term Investments | 125.87 | 116.15 | 69.80 | 40.36 |
Accounts Receivable- Trade Net | 49.26 | 37.43 | 33.59 | 57.42 |
Total Receivables Net | 64.34 | 37.45 | 45.95 | 72.49 |
Total Inventory | 103.62 | 95.05 | 90.62 | 62.55 |
Prepaid Expenses | 3.05 | - | 0.08 | 0.06 |
Other Current Assets Total | 1.21 | 15.40 | 0.46 | 0.39 |
Total Current Assets | 298.09 | 264.05 | 206.91 | 175.85 |
Property/ Plant/ Equipment Total- Gross | 236.15 | 15.03 | 143.33 | 122.23 |
Accumulated Depreciation Total | -54.34 | - | -43.24 | -34.29 |
Property/ Plant/ Equipment Total- Net | 181.81 | 116.30 | 100.09 | 87.94 |
Intangibles Net | 28.03 | 33.40 | 34.68 | 37.13 |
Long Term Investments | 1.01 | - | 0.38 | - |
Note Receivable- Long Term | 2.92 | 1.91 | 1.37 | 2.13 |
Other Long Term Assets Total | 1.01 | 3.69 | 1.18 | 0.34 |
Total Assets | 512.87 | 419.35 | 344.61 | 303.39 |
Accounts Payable | 71.02 | 64.69 | 45.50 | 47.44 |
Accrued Expenses | 29.18 | - | 10.48 | 9.84 |
Notes Payable/ Short Term Debt | 0.00 | 0.01 | 0.28 | 0.52 |
Current Portof LT Debt/ Capital Leases | 0.00 | 0.00 | 0.36 | 0.76 |
Other Currentliabilities Total | 30.76 | 38.08 | 23.49 | 21.13 |
Total Current Liabilities | 130.96 | 102.78 | 80.11 | 79.69 |
Capital Lease Obligations | 0.00 | 0.00 | 0.29 | 0.19 |
Total Long Term Debt | 0.00 | 0.00 | 0.30 | 0.74 |
Total Debt | 0.00 | 0.01 | 0.94 | 2.02 |
Other Liabilities Total | 7.06 | 7.00 | 6.17 | 6.51 |
Total Liabilities | 138.02 | 111.75 | 88.84 | 86.94 |
Common Stock Total | 13.23 | 13.23 | 13.23 | 13.23 |
Additional Paid- In Capital | 34.46 | - | 34.46 | 34.46 |
Retained Earnings( Accumulated Deficit) | 327.16 | 294.37 | 208.08 | 168.76 |
Total Equity | 374.85 | 307.60 | 255.77 | 216.45 |
Total Liabilities Shareholders' Equity | 512.87 | 419.35 | 344.61 | 303.39 |
Total Common Shares Outstanding | 1.65 | 1.65 | 1.65 | 1.65 |
Tangible Book Valueper Share Common Eq | 209.70 | 165.79 | 133.68 | 108.42 |
period Length | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Debt | - | 0.00 | 0.01 | 0.55 |
Deferred Income Tax | - | 1.97 | 2.26 | - |
Rpg Life Sciences Dividend Rpg Life Sciences Bonus Rpg Life Sciences News Rpg Life Sciences AGM Rpg Life Sciences Rights Rpg Life Sciences Splits Rpg Life Sciences Board Meetings Rpg Life Sciences Key Metrics Rpg Life Sciences Shareholdings Rpg Life Sciences Profit Loss Rpg Life Sciences Cashflow Rpg Life Sciences Q1 Results Rpg Life Sciences Q2 Results Rpg Life Sciences Q3 Results Rpg Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks